Free Trial
NASDAQ:IMTX

Immatics (IMTX) Stock Price, News & Analysis

Immatics logo
$6.65 +0.04 (+0.61%)
Closing price 08/5/2025 04:00 PM Eastern
Extended Trading
$6.55 -0.10 (-1.50%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Immatics Stock (NASDAQ:IMTX)

Key Stats

Today's Range
$6.51
$6.66
50-Day Range
$5.14
$6.68
52-Week Range
$3.30
$13.09
Volume
243,055 shs
Average Volume
394,198 shs
Market Capitalization
$808.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.67
Consensus Rating
Buy

Company Overview

Immatics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

IMTX MarketRank™: 

Immatics scored higher than 44% of companies evaluated by MarketBeat, and ranked 1244th out of 1,841 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Immatics has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Immatics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Immatics' stock forecast and price target.
  • Earnings Growth

    Earnings for Immatics are expected to decrease in the coming year, from ($0.72) to ($1.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Immatics is -39.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Immatics is -39.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Immatics has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Immatics' valuation and earnings.
  • Percentage of Shares Shorted

    3.15% of the outstanding shares of Immatics have been sold short.
  • Short Interest Ratio / Days to Cover

    Immatics has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in Immatics has recently decreased by 5.90%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Immatics does not currently pay a dividend.

  • Dividend Growth

    Immatics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.15% of the outstanding shares of Immatics have been sold short.
  • Short Interest Ratio / Days to Cover

    Immatics has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in Immatics has recently decreased by 5.90%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 3 people have searched for IMTX on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Immatics to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Immatics insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    64.41% of the stock of Immatics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Immatics' insider trading history.
Receive IMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immatics and its competitors with MarketBeat's FREE daily newsletter.

IMTX Stock News Headlines

If you saw this, you'd be scared too
Markets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ years of navigating crashes and crises, he says traditional strategies could soon become wealth destroyers. A time-sensitive briefing reveals what to do now.
Immatics: Taking Off On A PRAME Rocketship
See More Headlines

IMTX Stock Analysis - Frequently Asked Questions

Immatics' stock was trading at $7.11 at the start of the year. Since then, IMTX stock has decreased by 6.5% and is now trading at $6.65.

Immatics N.V. (NASDAQ:IMTX) released its earnings results on Tuesday, May, 13th. The company reported ($0.35) earnings per share for the quarter, beating analysts' consensus estimates of ($0.39) by $0.04. The business earned $20.12 million during the quarter, compared to the consensus estimate of $14.92 million. Immatics had a negative net margin of 14.73% and a negative trailing twelve-month return on equity of 4.52%.

Top institutional shareholders of Immatics include TD Asset Management Inc (0.24%), Vanguard Personalized Indexing Management LLC (0.04%), Simplex Trading LLC and Vontobel Holding Ltd. (0.01%).

Shares of IMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immatics investors own include Broadcom (AVGO), Datadog (DDOG), Advanced Micro Devices (AMD), Moderna (MRNA), Cloudflare (NET) and QUALCOMM (QCOM).

Company Calendar

Last Earnings
5/13/2025
Today
8/06/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMTX
CIK
1809196
Fax
N/A
Employees
260
Year Founded
N/A

Price Target and Rating

High Price Target
$19.00
Low Price Target
$10.00
Potential Upside/Downside
+120.6%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.17)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$16.47 million
Net Margins
-14.73%
Pretax Margin
-11.63%
Return on Equity
-4.52%
Return on Assets
-3.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.28
Quick Ratio
10.28

Sales & Book Value

Annual Sales
$168.65 million
Price / Sales
4.79
Cash Flow
$0.25 per share
Price / Cash Flow
27.05
Book Value
$5.12 per share
Price / Book
1.30

Miscellaneous

Outstanding Shares
121,550,000
Free Float
N/A
Market Cap
$808.31 million
Optionable
Optionable
Beta
0.93
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:IMTX) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners